Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 05 2022 - 3:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of
May, 2022.
____________________
Commission File
Number: 001-40627
SOPHiA GENETICS SA
(Exact name of registrant as specified in its
charter)
Rue du Centre
172
CH-1025 Saint-Sulpice
Switzerland
(Address of principal executive office)
Indicate by check
mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
SOPHiA GENETICS SA |
Date: May 5, 2022 |
|
|
|
|
By: |
/s/ Daan van Well |
|
Name: |
Daan van Well |
|
Title: |
Chief Legal Officer |
EXHIBIT INDEX
Exhibit No. |
Description |
99.1 |
Press release dated May 5, 2022 |
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jul 2023 to Jul 2024